Exchange

Zomedica expands topline because of acquisitions and natural development (NYSE:ZOM)

CharlieAJA/iStock through Getty Images Announcing financials for 2022, animal well being firm Zomedica (NYSE:ZOM) mentioned Wednesday that its income for the total yr jumped ~361% to $18.9M via a mixture

By Staff 2 Min Read